AVTX Avalo Therapeutics, Inc.

Fundamentals / CIK 0001534120 / USD

Avalo Therapeutics, Inc. reported $59K in revenue and a net loss of $88.65M for the fiscal year ended December 31, 2025 (down 86.6% year over year), with a -161961.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AVTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$36.32M$18.16M$0-$81.26MFY 2016 Revenue: $1.15MFY 2016 Net Income: -$16.47M2016FY 2017 Revenue: $27.81MFY 2017 Net Income: $11.87M2017FY 2018 Revenue: $7.03MFY 2018 Net Income: -$40.05M2018FY 2019 Revenue: $6.75MFY 2019 Net Income: -$16.07M2019FY 2020 Revenue: $6.70MFY 2020 Net Income: -$63.50M2020FY 2021 Revenue: $5.40MFY 2021 Net Income: -$84.38M2021FY 2022 Revenue: $18.05MFY 2022 Net Income: -$41.66M2022FY 2023 Revenue: $1.92MFY 2023 Net Income: -$31.54M2023FY 2024 Revenue: $441KFY 2024 Net Income: -$35.13M2024FY 2025 Revenue: $59KFY 2025 Net Income: -$78.26M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $59K $441K $1.92M $18.05M $5.40M $6.70M $6.75M $7.03M $27.81M $1.15M
Cost of Revenue -- -- $1.28M $3.43M $1.49M $300K -$567K $3.26M $636K $0
Gross Profit -- -- $640K $14.62M $3.91M $6.40M $7.32M $3.77M $27.18M $1.15M
Research & Development $50.08M $24.44M $13.78M $31.31M $59.84M $32.19M $11.76M $5.79M $4.37M $10.15M
Selling, General & Admin -- -- $10.30M $20.71M $27.48M $19.76M $11.61M $11.06M $8.51M $7.08M
Total Operating Expenses -- -- -- -- -- -- -- $57.64M $13.92M $17.23M
Operating Income -$72.92M -$68.51M -$27.35M -$37.44M -$82.13M -$72.84M -$16.14M -$35.38M $13.89M -$16.08M
EBITDA -$72.58M -$68.34M -$27.19M -$37.27M -$80.48M -$71.00M -$12.25M -$30.82M $14.32M -$16.05M
Income Before Tax -$78.09M -$35.02M -$31.53M -$41.63M -- -- -- -- -- --
Income Tax Expense $165K $114K $14K $28K -$196K -$2.79M $280K -$49K $1.97M $0
Net Income -$78.26M -$35.13M -$31.54M -$41.66M -$84.38M -$63.50M -$16.07M -$40.05M $11.87M -$16.47M
Basic EPS -$5.84 -$7.94 -$113.58 -$1,063.00 -- -- -- -$3,429.94 $1,200.48 -$5,345.00
Diluted EPS -$5.84 -$20.91 -$113.58 -$1,063.00 -- -- -- -$3,429.94 $1,200.48 -$5,345.00
Basic Shares Outstanding 13.4M 4.4M 277.7K 39.2K -- -- -- 12.2K 6.4K 3.1K
Diluted Shares Outstanding 13.4M 7.5M 277.7K 39.2K -- -- -- 12.2K 6.6K 3.1K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- $0 -- -- $192K
Cost of Revenue -- -- -- -- -- $0 -- --
Research & Development $15.05M $23.42M $14.05M $13.27M $13.62M $14.07M $9.12M $8.18M
Operating Income -$23.40M -$31.52M -$20.90M -$19.74M -$19.20M -$19.32M -$14.67M -$13.31M
EBITDA -$23.38M -$31.50M -$20.88M -$19.73M -$19.14M -$19.18M -$14.53M -$13.24M
Income Before Tax -$18.94M -$36.34M -$19.62M -$13.59M -$30.61M -$20.75M -$13.14M -$35.23M
Income Tax Expense $7.0K $18K $12K $130K $11K $16K $8.0K $114K
Net Income -$18.95M -$36.36M -$19.63M -$13.72M -$30.62M -$20.77M -$13.15M -$35.34M
Basic EPS -$0.34 -$0.83 -$0.98 -- -$2.19 -$1.92 -$1.25 --
Diluted EPS -$0.34 -$0.83 -$0.98 -- -$2.19 -$1.92 -$1.25 --
Basic Shares Outstanding 55.1M 43.6M 20.1M -- 14.0M 10.8M 10.5M --
Diluted Shares Outstanding 55.1M 43.6M 20.1M -- 14.0M 10.8M 10.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $15.86M $134.5M $7.42M $13.17M $54.59M $18.92M $3.61M $10.65M $2.47M $5.13M
Short-Term Investments $82.48M $0 -- -- -- -- -- -- -- --
Cash & Short-Term Investments $98.30M $134.5M $7.42M $13.17M $54.59M $18.92M $3.61M $10.65M $2.47M $5.13M
Accounts Receivable, Net -- -- -- $0 $1.06M $2.18M $1.00M $822K $2.94M $132K
Inventory -- -- $0 $20K $38K $3.0K $21K $318K $382K $0
Total Current Assets $105.3M $138.9M $8.39M $16.42M $61.84M $26.00M $17.72M $21.93M $10.67M $5.66M
Property, Plant & Equipment, Net -- -- -- -- -- -- $1.45M $587K $45K $43K
Goodwill $10.50M $10.50M $10.50M $14.41M $14.41M $14.41M $14.41M $14.41M $12.29M $0
Intangible Assets -- -- -- $0 $38K $1.58M $2.43M $3.77M $17.66M $0
Long-Term Investments $0 -- -- -- -- -- -- -- -- --
Total Non-Current Assets $11.17M $11.84M $12.60M $16.95M $18.37M $17.75M $18.38M $48.32M $32.13M $106K
Total Assets $116.5M $150.7M $20.99M $33.37M $80.21M $43.76M $36.11M $70.25M $42.81M $5.77M
Accounts Payable $137K $283K $446K $2.88M $3.37M $2.57M $2.08M $1.45M $1.30M $1.01M
Short-Term Debt -- -- -- -- -- -- -- $1.05M $0 $2.35M
Deferred Revenue (Current) -- -- $0 $88K $0 -- -- -- $0 --
Total Current Liabilities $12.94M $6.96M $4.62M $22.11M $19.89M $15.22M $12.16M $26.22M $11.09M $4.31M
Long-Term Debt -- -- -- -- -- -- -- $14.33M $0 $0
Other Non-Current Liabilities $35K $350K $1.37M $1.71M $2.30M $1.88M $1.11M $386K $24K $0
Total Non-Current Liabilities $20.47M $10.74M $9.07M $22.17M $37.24M $3.97M $2.95M $23.13M $3.86M $1.25M
Total Liabilities $33.41M $17.70M $13.69M $44.28M $57.13M $19.19M $15.11M $49.34M $14.95M $5.56M
Total Debt (incl. Leases) $427K $918K $1.90M $2.24M $2.50M $1.46M $1.27M $15.38M $0 $2.35M
Common Stock $18K $10K $1.0K $0 $9.0K $75K $44K $41K $31K $9.4K
Retained Earnings -$448.5M -$370.3M -$335.1M -$303.8M -$262.2M -$177.8M -$114.3M -$98.22M -$58.17M -$70.04M
Accumulated Other Comp. Income $68K $0 -- -- -- -- -- -- -- --
Total Stockholders' Equity $83.05M $133.0M $7.30M -$10.91M $23.08M $24.56M $21.00M $20.91M $27.86M $207K
Total Equity $83.05M $133.0M $7.30M -$10.91M $23.08M $24.56M $21.00M $20.91M $27.86M $207K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $64.99M $85.38M $24.99M $15.86M $26.96M $42.29M $125.0M $134.5M
Short-Term Investments $328.0M $314.9M $57.01M $82.48M $84.65M $70.97M -- $0
Cash & Short-Term Investments $462.8M $472.2M $82.00M $98.30M $111.6M $113.3M $125.0M $134.5M
Total Current Assets $400.7M $407.9M $88.83M $105.3M $113.8M $115.2M $126.9M $138.9M
Goodwill $10.50M $10.50M $10.50M $10.50M $10.50M $10.50M $10.50M $10.50M
Long-Term Investments $69.81M $71.88M -- $0 -- -- -- --
Total Non-Current Assets $80.69M $82.85M $11.06M $11.17M $11.25M $11.40M $11.58M $11.84M
Total Assets $481.4M $490.8M $99.89M $116.5M $125.1M $126.6M $138.5M $150.7M
Accounts Payable $2.46M $3.35M $356K $137K $474K $2.37M $681K $283K
Total Current Liabilities $24.09M $21.13M $11.60M $12.94M $7.97M $9.26M $5.62M $6.96M
Other Non-Current Liabilities $0 $0 $0 $35K $117K $197K $275K $350K
Total Non-Current Liabilities $20.79M $20.99M $19.97M $20.47M $25.58M $12.75M $10.29M $10.74M
Total Liabilities $44.88M $42.12M $31.57M $33.41M $33.55M $22.01M $15.91M $17.70M
Total Debt (incl. Leases) $153K $242K $328K $427K $555K $679K $801K $918K
Common Stock $54K $53K $25K $18K $18K $11K $11K $10K
Retained Earnings -$523.5M -$504.5M -$468.2M -$448.5M -$434.8M -$404.2M -$383.4M -$370.3M
Accumulated Other Comp. Income -$1.51M -$583K -$6.0K $68K $41K -$34K -- $0
Total Stockholders' Equity $436.5M $448.7M $68.32M $83.05M $91.55M $104.6M $122.6M $133.0M
Total Equity $436.5M $448.7M $68.32M $83.05M $91.55M $104.6M $122.6M $133.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$78.26M -$35.13M -$31.54M -$41.66M -$84.38M -$63.50M -$16.07M -$40.05M $11.87M -$16.47M
Depreciation & Amortization $344K $169K $158K $166K $1.66M $1.84M $3.88M $4.55M $425K $27K
Stock-Based Compensation $13.62M $5.85M $3.48M $7.55M $8.17M $6.79M $2.53M $2.43M $1.16M $1.69M
Change in Receivables -- -- $0 $1.06M $1.12M -$678K $1.66M -$223K -$247K -$132K
Change in Inventory -- $0 $20K $18K -$35K $18K $533K -$311K -$24K $0
Change in Payables -$146K -$163K -$2.44M -$487K $796K $99K $1.02M $82K $96K $332K
Operating Cash Flow -$51.46M -$49.06M -$30.68M -$26.75M -$70.89M -$40.54M -$19.13M -$3.13M $12.58M -$14.57M
Capital Expenditure -- -- $0 -$95K -$113K -$63K -$262K -$564K -$23K -$35K
Free Cash Flow -- -- -$30.68M -$26.85M -$71.00M -$40.60M -$19.40M -$3.69M $12.56M -$14.61M
Acquisitions, Net -- -- -- -- -- -- $0 -$1 -$18.89M $0
Investing Cash Flow -$81.72M $356K -$133K -$95K -$113K $11.13M -$443K $865K -$18.91M -$35K
Common Stock Issued $14.76M $0 $32.47M $0 $29.05M $35.43M $8.98M $0 $1.69M $2.00M
Financing Cash Flow $14.59M $175.8M $25.04M -$14.70M $106.8M $44.78M $12.56M $10.40M $3.74M -$1.43M
Net Change in Cash -$118.6M $127.1M -$5.77M -$41.55M $35.76M $15.38M -$7.02M $8.14M -$2.60M -$16.03M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$18.95M -$36.36M -$19.63M -$13.72M -$30.62M -$20.77M -$13.15M -$35.34M
Depreciation & Amortization $18K $17K $17K $16K $59K $134K $135K $68K
Stock-Based Compensation $5.22M $5.30M $3.58M $4.51M $3.15M $2.72M $3.24M $2.90M
Change in Inventory -- -- -- -- -- -- -- $0
Change in Payables -$889K $2.99M $219K -$337K -$1.89M $1.69M $398K -$1.53M
Operating Cash Flow -$11.54M -$19.99M -$17.69M -$14.25M -$16.36M -$11.39M -$9.46M -$15.04M
Investing Cash Flow -$11.23M -$329.9M $25.50M $2.40M -$13.26M -$70.86M $0 $0
Financing Cash Flow $2.54M $410.2M $1.40M $687K $14.37M -$469K $0 $67.71M
Net Change in Cash -$20.23M $60.30M $9.21M -$11.16M -$15.26M -$82.72M -$9.46M $52.66M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- 33.3% 81.0% 72.4% 95.5% 108.4% 53.6% 97.7% 100.0%
Operating Margin -123601.7% -15535.6% -1421.6% -207.4% -1521.6% -1087.4% -239.1% -503.4% 49.9% -1394.6%
Net Profit Margin -132642.4% -7965.8% -1639.5% -230.8% -1563.1% -947.9% -238.1% -569.9% 42.7% -1428.6%
Return on Equity (ROE) -94.2% -26.4% -431.9% -- -365.5% -258.5% -76.6% -191.6% 42.6% -7957.2%
Return on Assets (ROA) -67.2% -23.3% -150.3% -124.8% -105.2% -145.1% -44.5% -57.0% 27.7% -285.5%
Current Ratio 8.14x 19.96x 1.82x 0.74x 3.11x 1.71x 1.46x 0.84x 0.96x 1.31x
Quick Ratio 7.60x 19.33x 1.82x 0.74x 3.11x 1.71x 1.46x 0.82x 0.93x 1.31x
Debt to Equity 0.01x 0.01x 0.26x -- 0.11x 0.06x 0.06x 0.74x 0.00x 11.37x
Revenue Growth (YoY) -86.6% -77.1% -89.3% +234.4% -19.4% -0.8% -4.0% -74.7% +2312.3% --
Gross Profit Growth (YoY) -- -- -95.6% +274.1% -38.9% -12.5% +94.2% -86.1% +2257.1% --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -354.7% -- --
Net Income Growth (YoY) -- -- -- -- -- -- -- -437.4% -- --
EPS Growth (YoY) -- -- -- -- -- -- -- -385.7% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -124.9% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -129.4% -- --
5Y Revenue / Share Growth -- -- -98.8% -89.3% -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -157.7% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -- -15536.1%
Net Profit Margin -- -- -- -- -- -- -- -7965.8%
Return on Equity (ROE) -20.3% -22.4% -124.0% -94.2% -109.1% -44.2% 59.5% -26.4%
Return on Assets (ROA) -18.4% -20.4% -84.8% -67.2% -79.8% -36.5% 52.7% -23.3%
Current Ratio 16.63x 19.31x 7.66x 8.14x 14.28x 12.44x 22.61x 19.96x
Quick Ratio 19.21x 22.35x 7.07x 7.60x 14.00x 12.24x 22.27x 19.33x
Debt to Equity 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x 0.01x 0.01x
Revenue Growth (YoY) -- -- -- -- -100.0% -- -- -66.4%
Net Income Growth (YoY) -- -- -- -- -232.9% -121.1% -- --
EPS Growth (YoY) -- -- -- -- -323.5% -145.6% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001534120) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:38 UTC · Open in terminal